麻豆国产精品一二三在线观-麻豆国产精品一二三在线观看-麻豆国产精品一区二区-麻豆国产精品永久免费视频-麻豆国产巨作av剧情-麻豆国产蜜桃臀视频在线观看

美國Covance Research Products(CRP)   
CRP，即Covance Research Products，專為生物醫(yī)學(xué)和生物制藥學(xué)產(chǎn)業(yè)提供產(chǎn)品和服務(wù)，產(chǎn)品涵蓋實(shí)驗(yàn)動物、抗體、試劑盒等，尤以神經(jīng)科學(xué)產(chǎn)品見長。
三十年來，位于美國的Covance Research Products公司為生物醫(yī)學(xué)研究提供實(shí)驗(yàn)動物和相關(guān)服務(wù)。CRP還提供抗體產(chǎn)品和相關(guān)服務(wù)，轉(zhuǎn)基因克隆管理服務(wù)并進(jìn)行臨床外科學(xué)設(shè)備研究。

CRP是第一家建立血統(tǒng)清晰的商業(yè)用克隆兔的公司，成功的建立了Caesarean來源的的克隆兔，首先生產(chǎn)雜交兔,并為畸胎學(xué)研究人員提供商業(yè)化定時交配兔。從只擁有單一的飼養(yǎng)場所發(fā)展至今，CRP已經(jīng)擁有五個養(yǎng)殖點(diǎn)，包括家兔，豚鼠,犬和靈長類動物。自1998年11月與伯克利抗體公司(BabCO)合并后，CRP在抗體供應(yīng)和服務(wù)業(yè)務(wù)上進(jìn)展迅速，并擴(kuò)大了其在創(chuàng)新外科方面的研究能力。

Covance Pharmaceutical Research and Development (Shanghai) Co., Ltd.
Building #3, No. 3377 Kangxin Rd.
SIMZ Pudong
Shanghai 201318, China


CRP公司提供已經(jīng)獲得ISO9002，AAALAC等認(rèn)證的儀器設(shè)備，為藥物開發(fā)客戶提供高質(zhì)量、高效率的產(chǎn)品和服務(wù)，是CRP一貫的宗旨。

關(guān)于CRP的產(chǎn)品和服務(wù)

實(shí)驗(yàn)動物
犬類：beagles,mongrels,mini-mongrels,hounds
兔類：New Zealand White，Dutch Belted，Watanabe，Californian，Inbred NZW
豚鼠:突變鼠
靈長類動物：Cynomolgus,Rhesus
豬：Domestic Yorkshire
CRP能夠利用各種各樣的外科手術(shù)對其訂購的動物進(jìn)行手術(shù)，除此以外，CRP公司還提供行為加強(qiáng)服務(wù)，例如對實(shí)驗(yàn)動物進(jìn)行踏車訓(xùn)練或適應(yīng)實(shí)驗(yàn)環(huán)境的相關(guān)訓(xùn)練。

創(chuàng)新外科和研究服務(wù)
CRP提供一系列的創(chuàng)新外科和研究服務(wù)，支持藥物開發(fā)和醫(yī)學(xué)設(shè)備研究，除此以外還進(jìn)行GLP研究。安裝動物的動脈導(dǎo)管和醫(yī)學(xué)設(shè)備開發(fā)在7500平方英尺的外科實(shí)驗(yàn)室完成。

抗體產(chǎn)品和服務(wù)
CRP提供創(chuàng)新抗體產(chǎn)品和定制抗體服務(wù)。客戶可以與本公司擁有廣泛經(jīng)驗(yàn)的科學(xué)團(tuán)隊合作而受益，公司能幫助客戶選擇有效抗體產(chǎn)品，提供客戶自定義服務(wù)。
定制服務(wù)包括
多克隆抗體產(chǎn)品
雜交細(xì)胞系的開發(fā)
單克隆抗體的開發(fā)(體外)
新型抗體產(chǎn)品家族
抗原決定簇抗體
細(xì)胞標(biāo)記物和受體
細(xì)胞骨架和細(xì)胞表面蛋白
轉(zhuǎn)錄因子和信號傳導(dǎo)

Covance — one of the world's largest and most comprehensive drug development services companies — has the people, global resources and problem-solving culture to respond to pharmaceutical and biotechnology clients' toughest drug development challenges.

We provide a portfolio of preclinical and clinical development and commercial service offerings — delivered through industry-leading nonclinical testing services, the world's largest central laboratory network, and a global team of clinical trial professionals.
About Covance
Covance Company Overview

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and more than 8,900 employees worldwide. Offering drug development solutions from preclinical through commercialization, Covance is a world-class provider of the following service lines:

Research products
Antibody products and services
Nonclinical development services
Risk management services
Clinical pharmacology services
Central laboratory/Covance local laboratory services
Cardiac safety services
Clinical development services
Commercialization services
Covance — Meeting Your Needs

With a commitment to meeting your needs, Covance offers unparalleled expertise, experience and results. Covance knows the significant pressures pharmaceutical and biotechnology companies of all sizes face in developing and launching drugs backed by strong data.

With a business built around your needs, our streamlined approach to drug development means high quality, error-free data designed to help bring your drug to market as quickly, safely and cost effectively as possible, including:

Proving early safety
Conducting first in human studies
Conducting proof of concept studies
Proving clinical safety and efficacy
Filing for marketing approval
Launching and marketing a drug
Ensuring patient safety and access
Managing risk
Managing over 15,000 clinical trial protocols in 100 countries on 6 continents, Covance provides the experience and exceptional customer service to advance your compound along the drug development continuum. Strategic partnerships built on decades of success — Covance is dedicated to helping bring your miracles to market sooner.
In the late 1980s and early 1990s, Corning, Incorporated acquired numerous best-of-class drug development companies, some with roots dating back to the 1940s. In January 1997, Corning spun off these businesses as one publicly-traded, independent company called Covance Inc. [NYSE: CVD].

Covance Today
Today, from its corporate headquarters in Princeton, NJ, Covance has grown into one of the world's largest and most respected global drug development services companies. Moving forward, Covance continues to broaden its capabilities by strategic acquisition and in-house development. The Company's primary focus is serving the pharmaceutical and biotech industries offering a broad range of services — from nonclinical research to clinical development to commercialization services.